Peter F. Wright

Pediatrics

1 Medical Center Dr
Lebanon, NH 03756

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 85 publications

Molecular-level analysis of serum IgG repertoires in COVID-19-vaccinated people with cystic fibrosis identifies abundant convergent antibodies.

Molecular-level analysis of serum IgG repertoires in COVID-19-vaccinated people with cystic fibrosis identifies abundant convergent antibodies.

Journal: bioRxiv : the preprint server for biology

Published: July 17, 2026

Intranasal Replicating Adenovirus type 4-SARS-CoV-2 Recombinants Induce Superior Immune Response Durability and Efficacy in Preclinical Testing Compared to Standard Intramuscular Vaccines.

Intranasal Replicating Adenovirus type 4-SARS-CoV-2 Recombinants Induce Superior Immune Response Durability and Efficacy in Preclinical Testing Compared to Standard Intramuscular Vaccines.

Journal: bioRxiv : the preprint server for biology

Published: April 29, 2026

Effect of inactivated poliovirus vaccine on nasal mucosal immunity and pharyngeal shedding following novel oral poliovirus vaccine type 2 challenge: A randomized, open-label trial.

Effect of inactivated poliovirus vaccine on nasal mucosal immunity and pharyngeal shedding following novel oral poliovirus vaccine type 2 challenge: A randomized, open-label trial.

Journal: The Journal of infectious diseases

Published: February 09, 2026

Vaccine and Treatment Evaluation Units: A Historical Perspective.

Vaccine and Treatment Evaluation Units: A Historical Perspective.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Published: October 10, 2025

The Search for a Respiratory Syncytial Virus Vaccine.

The Search for a Respiratory Syncytial Virus Vaccine.

Journal: NEJM evidence

Published: August 26, 2025

Intranasal replicating adenovirus type 4-vectored SARS-CoV-2 vaccines induce durable and efficacious responses in preclinical testing.

Intranasal replicating adenovirus type 4-vectored SARS-CoV-2 vaccines induce durable and efficacious responses in preclinical testing.

Journal: iScience

Published: June 13, 2025

Intestinal Mucosal Immune Responses to Novel Oral Poliovirus Vaccine Type 2 in Healthy Newborns.

Intestinal Mucosal Immune Responses to Novel Oral Poliovirus Vaccine Type 2 in Healthy Newborns.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Published: May 08, 2025

Safety and immunogenicity of novel live attenuated type 1 and type 3 oral poliomyelitis vaccines in healthy adults in the USA: a first-in-human, observer-masked, multicentre, phase 1 randomised controlled trial.

Safety and immunogenicity of novel live attenuated type 1 and type 3 oral poliomyelitis vaccines in healthy adults in the USA: a first-in-human, observer-masked, multicentre, phase 1 randomised controlled trial.

Journal: The Lancet. Infectious diseases

Published: January 31, 2025

Binding and neutralising antibodies to respiratory syncytial virus and influenza A virus in serum and bronchoalveolar lavage fluid of healthy adults in the United States: A cross-sectional study.

Binding and neutralising antibodies to respiratory syncytial virus and influenza A virus in serum and bronchoalveolar lavage fluid of healthy adults in the United States: A cross-sectional study.

Journal: Vaccine

Published: October 11, 2024

Nasal and Pharyngeal Mucosal Immunity to Poliovirus in Children Following Routine Immunization With Inactivated Polio Vaccine in the United States.

Nasal and Pharyngeal Mucosal Immunity to Poliovirus in Children Following Routine Immunization With Inactivated Polio Vaccine in the United States.

Journal: The Journal of infectious diseases

Published: April 03, 2024

Characteristics and Functions of Infection-enhancing Antibodies to the N-terminal Domain of SARS-CoV-2.

Characteristics and Functions of Infection-enhancing Antibodies to the N-terminal Domain of SARS-CoV-2.

Journal: Pathogens & immunity

Published: February 05, 2024

Characteristics and functions of infection-enhancing antibodies to the N-terminal domain of SARS-CoV-2.

Characteristics and functions of infection-enhancing antibodies to the N-terminal domain of SARS-CoV-2.

Journal: bioRxiv : the preprint server for biology

Published: October 03, 2023

Showing 1-12 of 85

Last Updated: 09/26/2026